DIFFERENCES IN MYRISTIC ACID SYNTHESIS AND IN METABOLIC-RATE FOR P388 CELLS RESISTANT TO DOXORUBICIN

被引:0
|
作者
WILDER, PJ [1 ]
OVERMAN, DK [1 ]
TENENHOLZ, TC [1 ]
GUTIERREZ, PL [1 ]
机构
[1] UNIV MARYLAND,CTR CANC,SCH MED,DIV DEV THERAPEUT,655 W BALTIMORE ST,BALTIMORE,MD 21201
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:1973 / 1982
页数:10
相关论文
共 50 条
  • [1] ALTERED METABOLIC-RATE AND FATTY-ACID DISTRIBUTION IN ADRIAMYCIN RESISTANT P388 CELLS
    WILDER, PJ
    OVERMAN, D
    TENENHOLZ, T
    KAPLAN, R
    GUTIERREZ, PL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 318 - 318
  • [2] DIFFERENCES IN LIPID-COMPOSITION OF DOXORUBICIN-SENSITIVE AND DOXORUBICIN-RESISTANT P388 CELLS
    RAMU, A
    GLAUBIGER, D
    WEINTRAUB, H
    CANCER TREATMENT REPORTS, 1984, 68 (04): : 637 - 641
  • [3] INCREASED RADIATION SENSITIVITY OF P388 CELLS RESISTANT TO DOXORUBICIN (P388-ADR)
    GLAUBIGER, D
    RAMU, A
    COHEN, L
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 258 - 258
  • [4] ELECTROKINETIC DIFFERENCES BETWEEN DOXORUBICIN SENSITIVE AND RESISTANT P388 MOUSE LEUKEMIC-CELLS
    NAIR, S
    HORTON, A
    LEIF, RC
    SAMY, TSA
    KRISHAN, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 265 - 265
  • [5] BIOCHEMICAL AND MORPHOLOGICAL-STUDIES IN P388 SENSITIVE AND DOXORUBICIN RESISTANT (P388 DX) LEUKEMIA-CELLS
    FACCHINETTI, T
    MALISANO, G
    SALARDI, S
    GERONI, C
    BELLINI, O
    ESPOSITO, G
    GIULIANI, FC
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 343 - 343
  • [6] Effects of xanthine derivatives on the influx and efflux of doxorubicin in P388 and DOX-resistant P388 leukemia cells
    Sadzuka, Y
    Egawa, Y
    Sawanishi, H
    Miyamoto, K
    Sonobe, T
    TOXICOLOGY LETTERS, 2002, 135 (1-2) : 137 - 144
  • [7] Apoptosis induced by doxorubicin and cinchonine in P388 multidrug-resistant cells
    Furusawa, S
    Nakano, S
    Wu, JJ
    Sakaguchi, S
    Takayanagi, M
    Sasaki, KL
    Satoh, S
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (07) : 1029 - 1039
  • [8] DNA DAMAGE REPAIR IN DOXORUBICIN RESISTANT MURINE LEUKEMIC P388 CELLS
    MANIAR, N
    SAMY, TSA
    KRISHAN, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 265 - 265
  • [9] RESTORATION OF DOXORUBICIN RESPONSIVENESS IN DOXORUBICIN-RESISTANT P388 MURINE LEUKEMIA-CELLS
    RAMU, A
    SPANIER, R
    RAHAMIMOFF, H
    FUKS, Z
    BRITISH JOURNAL OF CANCER, 1984, 50 (04) : 501 - 507
  • [10] EVALUATION OF NEW ANTHRACYCLINES ON P388-LEUKEMIA SENSITIVE (P388/S) OR RESISTANT (P388/R) TO DOXORUBICIN (DX)
    GERONI, CM
    PODESTA, A
    BARBIERI, BM
    GIULIANI, FC
    CASAZZA, AM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 280 - 280